Idarubicin - CAS 58957-92-9

Idarubicin, a potent anthracycline antileukemic agent, is orally active in its application. It functions by inhibiting topoisomerase II, thus interfering with DNA replication and RNA transcription. Furthermore, Idarubicin induces DNA damage, inhibits DNA synthesis, and suppresses c-myc expression. It also demonstrates inhibitory effects on the growth of bacteria and yeasts [1] [2] [3] [4] [5].

Others, DNA/RNA Synthesis, Antifungal, Autophagy, c-Myc, Antibiotic, Antibacterial, Topoisomerase

Others, DNA Damage/DNA Repair, Autophagy, Microbiology/Virology, Cell Cycle/Checkpoint

58856

C26H27NO9

497.49

O([C@@H]1C2=C(C(O)=C3C(=C2O)C(=O)C=4C(C3=O)=CC=CC4)C[C@](C(C)=O)(O)C1)[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5

-20°C

Ice Packs

Small Compound